NU2

(3~{R},6~{R})-6-[(2~{S})-butan-2-yl]-3-(2,3-dihydro-1~{H}-inden-2-yl)-1-[(1~{R})-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxidanylidene-ethyl]piperazine-2,5-dione

Created: 2019-12-13
Last modified:  2020-08-05

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count70
Chiral Atom Count4
Bond Count74
Aromatic Bond Count11
2D diagram of NU2
Toggle HydrogenToggle Labels

Chemical Component Summary

Name(3~{R},6~{R})-6-[(2~{S})-butan-2-yl]-3-(2,3-dihydro-1~{H}-inden-2-yl)-1-[(1~{R})-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxidanylidene-ethyl]piperazine-2,5-dione
Systematic Name (OpenEye OEToolkits)(3~{R},6~{R})-6-[(2~{S})-butan-2-yl]-3-(2,3-dihydro-1~{H}-inden-2-yl)-1-[(1~{R})-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxidanylidene-ethyl]piperazine-2,5-dione
FormulaC27 H34 N4 O5
Molecular Weight494.583
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESCACTVS3.385CC[CH](C)[CH]1N([CH](C(=O)N2CCOCC2)c3coc(C)n3)C(=O)[CH](NC1=O)C4Cc5ccccc5C4
SMILESOpenEye OEToolkits2.0.7CCC(C)C1C(=O)NC(C(=O)N1C(c2coc(n2)C)C(=O)N3CCOCC3)C4Cc5ccccc5C4
Canonical SMILESCACTVS3.385 CC[C@H](C)[C@H]1N([C@@H](C(=O)N2CCOCC2)c3coc(C)n3)C(=O)[C@H](NC1=O)C4Cc5ccccc5C4
Canonical SMILESOpenEye OEToolkits2.0.7 CC[C@H](C)[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c2coc(n2)C)C(=O)N3CCOCC3)C4Cc5ccccc5C4
InChIInChI1.03 InChI=1S/C27H34N4O5/c1-4-16(2)23-25(32)29-22(20-13-18-7-5-6-8-19(18)14-20)26(33)31(23)24(21-15-36-17(3)28-21)27(34)30-9-11-35-12-10-30/h5-8,15-16,20,22-24H,4,9-14H2,1-3H3,(H,29,32)/t16-,22+,23+,24+/m0/s1
InChIKeyInChI1.03 PLVGDGRBPMVYPB-FDUHJNRSSA-N

Drug Info: DrugBank

DrugBank IDDB11818 
NameRetosiban
Groups investigational
DescriptionRetosiban has been used in trials studying the treatment of Premature Labor and Obstetric Labour, Premature.
SynonymsRetosiban
CAS number820957-38-8

Related Resource References

Resource NameReference
Pharos CHEMBL429736
PubChem 11340891
ChEMBL CHEMBL429736